Financial information, reports, calendar and more
Corporate Governance
Affibody Medical AB (publ) is Swedish a privately held limited liability company based in Stockholm.
The Company prepares Corporate Governance Reports in accordance with the Companies Act. In addition the Company complies with applicable parts of Code of Corporate Governance (the “Corporate Governance Code”).
The Corporate Governance Report including the auditor’s Review report is included in the Swedish Annual Report.
Affibodys latest Press releases
2018-09-24
New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report Q2 (August 23, 2018)